Although mesalazine does have an improved safety profile compared to sulphasalazine, it is not without side effects. The purpose of this systematic review is to evaluate the adverse effects of mesalazine therapy and whether there is any evidence that these occur in a dose‐dependent manner in the setting of treatment for ulcerative colitis. This review further seeks to advise practicing gastroenterologists on how best to prevent and manage these adverse events.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with P.
Contact P., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack